In this issue:
Semaglutide and automated insulin delivery in type 1 diabetes
Vitamin D supplementation and incident type 2 diabetes
Semaglutide in MASH
Tirzepatide and muscle composition changes in type 2 diabetes
IcoSema vs. icodec or basal-bolus insulin in type 2 diabetes
Altered brain function and structure in youth-onset type 2 diabetes
Finerenone and empagliflozin in chronic kidney disease and type 2 diabetes
High-dose semaglutide in type 2 diabetes and overweight/obesity
Long-term effects of lifestyle and metformin interventions on type 2 diabetes incidence
Please login below to download this issue (PDF)